Attached files
| file | filename |
|---|---|
| EX-99.1 - MedPro Safety Products, Inc. | v212047_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
report (Date of earliest event reported):
February
18, 2011
MEDPRO
SAFETY PRODUCTS, INC.
(Exact
Name of Registrant as Specified in its Charter)
|
Nevada
|
000-52077
|
91-2015980
|
||
|
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
File Number)
|
(IRS
Employee Identification No.)
|
817
Winchester Road, Suite 200
Lexington,
KY 40505
(Address
of Principal Executive Offices) (Zip Code)
(859)
225-5375
(Registrant’s
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
7.01 Regulation FD Disclosure.
On February 18, 2011, MedPro Safety Products, Inc. sent a letter to
its shareholders describing recent corporate developments. A copy of
the letter is attached as Exhibit 99.1 to this report.
Item
9.01. Financial Statement and Exhibits.
(d)
Exhibits.
|
Exhibit No.
|
Description
of Exhibit
|
|
|
99.1
|
Letter
to shareholders dated February 18,
2011
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this Report on Form 8-K to be signed on its behalf by the
undersigned hereunto duly authorized.
|
MEDPRO SAFETY PRODUCTS,
INC.
|
|||
|
Dated: February 18,
2011
|
By:
|
/s/ W. Craig
Turner
|
|
|
W. Craig
Turner
|
|||
|
Chairman and Chief Executive Officer
|
|||